Functional interaction between opioid and cannabinoid receptors in drug self-administration.

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633 · see citing works

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011 · see citing works

Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB 1 Receptor Knockout Mice

Ledent, C. A., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Impérato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,612 · see citing works

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913 · see citing works

Determination and characterization of a cannabinoid receptor in rat brain

Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · see citing works

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159 · see citing works

Naltrexone in the Treatment of Alcohol Dependence

Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828 · see citing works

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

Rinaldi, M. L., Barth, F., Héaulme, M., Shire, D. J., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,751 · see citing works

Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene

Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., et al. (1996) · Nature · doi:10.1038/383819a0 · Cited by 1,722 · see citing works

A second endogenous cannabinoid that modulates long-term potentiation

Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496 · see citing works

Molecular and Cellular Basis of Addiction

Nestler, E. J., & Aghajanian, G. K. (1997) · Science · doi:10.1126/science.278.5335.58 · Cited by 1,315 · see citing works

Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications

Mansour, A., Fox, C. A., Akil, H., & Watson, S. J. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93946-u · Cited by 1,297 · see citing works

Endogenous Opioids: Biology and Function

Akil, H., Watson, S. J., Young, E. A., Lewis, M. E., Khachaturian, H., & Walker, J. M. (1984) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.07.030184.001255 · Cited by 1,224 · see citing works

Cannabinoid and Heroin Activation of Mesolimbic Dopamine Transmission by a Common µ 1 Opioid Receptor Mechanism

Tanda, G., Pontieri, F. E., & Chiara, G. D. (1997) · Science · doi:10.1126/science.276.5321.2048 · Cited by 1,079 · see citing works

Neuroscience of addiction

Koob, G. F., Sanna, P. P., & Bloom, F. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)80557-7 · Cited by 1,026 · see citing works

Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

Giuffrida, A., Parsons, L. H., Kerr, T. M., de Fonseca, F. R., Navarro, M. A., & Piomelli, D. (1999) · Nature Neuroscience · doi:10.1038/7268 · Cited by 771 · see citing works

Localization of cannabinoid receptor mRNA in rat brain

Matsuda, L. A., Bonner, T. I., & Lolait, S. J. (1993) · Journal of Comparative Neurology · doi:10.1002/cne.903270406 · Cited by 631 · see citing works

Activation of Corticotropin-Releasing Factor in the Limbic System During Cannabinoid Withdrawal

Rodrı́guez de Fonseca, F., Carrera, M. R. A., Navarro, M., Koob, G. F., & Weiss, F. (1997) · Science · doi:10.1126/science.276.5321.2050 · Cited by 499 · see citing works

Pharmacology of Cannabinoid Receptors

Howlett, A. C. (1995) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.003135 · Cited by 493 · see citing works

Opioids: first lessons from knockout mice

Kieffer, B. L. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(98)01279-6 · Cited by 489 · see citing works

Cloning and pharmacological characterization of a rat μ opioid receptor

Thompson, R. C., Mansour, A., Akil, H., & Watson, S. J. (1993) · Neuron · doi:10.1016/0896-6273(93)90120-g · Cited by 451 · see citing works

Absence of opiate rewarding effects in mice lacking dopamine D2 receptors

Maldonado, R. J., Saiardi, A., Valverde, O., Samad, T. A., Roques, B. P., & Borrelli, E. (1997) · Nature · doi:10.1038/41567 · Cited by 431 · see citing works

CANNABINOID RECEPTORS AND THEIR ENDOGENOUS AGONISTS

Felder, C. C., & Glass, M. (1998) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.179 · Cited by 410 · see citing works

Pharmacological and biochemical interactions between opioids and cannabinoids

Manzanares, J., Corchero, J., Romero, J., Fernández‐Ruíz, J., Ramos, J. A., & Fuentes, J. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01339-5 · Cited by 391 · see citing works

Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys

Tanda, G., Munzar, P., & Goldberg, S. R. (2000) · Nature Neuroscience · doi:10.1038/80577 · Cited by 347 · see citing works

Δ9-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis

Chen, J., Paredes, W. M., Li, J., Smith, D. M., Lowinson, J. H., & Gardner, E. L. (1990) · Psychopharmacology · doi:10.1007/bf02245916 · Cited by 329 · see citing works

Effects of Chronic Treatment with Δ 9 -Tetrahydrocannabinol on Cannabinoid-Stimulated [ 35 S]GTPγS Autoradiography in Rat Brain

Sim, L. J., Hampson, R. E., Deadwyler, S. A., & Childers, S. R. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-24-08057.1996 · Cited by 311 · see citing works

Involvement of central cannabinoid (CB 1 ) receptors in the establishment of place conditioning in rats

Chaperon, F., Soubrié, P., Puech, A. J., & Thiébot, M.-H. (1998) · Psychopharmacology · doi:10.1007/s002130050518 · Cited by 280 · see citing works

Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions.

Gellert, V. F., & Holtzman, S. G. (1978) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)31261-9 · Cited by 265 · see citing works

Effects of chronic morphine administration on mu opioid receptor- stimulated [35S]GTPgammaS autoradiography in rat brain

Sim, L., De, S., Si, D., & Childers, S. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-08-02684.1996 · Cited by 263 · see citing works

Cannabinoid Transmission and Reward-Related Events

Gardner, E. L., & Vorel, S. R. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0219 · Cited by 247 · see citing works

Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice

Martín, M., Ledent, C. A., Parmentier, M., Maldonado, R. J., & Valverde, O. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00287.x · Cited by 237 · see citing works

Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist

Gallate, J. E., Saharov, T., Mallet, P. E., & McGregor, I. S. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00170-3 · Cited by 235 · see citing works

REDUCTION OF VOLUNTARY ETHANOL INTAKE IN ETHANOL-PREFERRING sP RATS BY THE CANNABINOID ANTAGONIST SR-141716

Colombo, G., Agabio, R., Fà, M., Guano, L., Loche, A., Reali, R., & Gessa, G. L. (1998) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a008368 · Cited by 226 · see citing works

Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal

Heinrichs, S. C., Menzaghi, F., Schulteis, G., Koob, G. F., & Stinus, L. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199501000-00011 · Cited by 226 · see citing works

Expression of Mu opioid receptor mRNA in rat brain: An in situ hybridization study at the single cell level

Delfs, J. M., Kong, H., Mestek, A., Chen, Y., Yu, L., Reisine, T., & Chesselet, M. (1994) · The Journal of Comparative Neurology · doi:10.1002/cne.903450104 · Cited by 218 · see citing works

Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice.

Welch, S. P., & Stevens, D. L. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10720-9 · Cited by 208 · see citing works

Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice

Martellotta, M. C., Cossu, G., Fattore, L., Gessa, G. L., & Fratta, W. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00052-9 · Cited by 202 · see citing works

Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with Δ‐9‐tetrahydrocannabinol

Hutcheson, D. M., Tzavara, E. T., Smadja, C., Valjent, E., Roques, B. P., Hanoune, J., & Maldonado, R. J. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702228 · Cited by 192 · see citing works

Mesolimbic dopaminergic decline after cannabinoid withdrawal

Diana, M., Melis, M., Muntoni, A. L., & Gessa, G. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10269 · Cited by 192 · see citing works

Cannabinoid receptor gene (CNR1): association with IV drug use

Comings, D. E., Muhleman, D. R., Gade, R., Johnson, P., Verde, R., Saucier, G., & MacMurray, J. P. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000247 · Cited by 175 · see citing works

Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats.

Diana, M., Pistis, M., Muntoni, A. L., & Gessa, G. L. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24484-6 · Cited by 170 · see citing works

CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats

Navarro, M., Chowen, J., Carrera, M. R. A., del Arco, I., Villanúa, M. A., Martin, Y., Roberts, A. J., Koob, G. F., & de Fonseca, F. R. (1998) · NeuroReport · doi:10.1097/00001756-199810260-00012 · Cited by 152 · see citing works

Morphine-Dependent Rats: Blockade of Precipitated Abstinence by Tetrahydrocannabinol

Hine, B., Friedman, E., Torrelio, M., & Gershon, S. (1975) · Science · doi:10.1126/science.1167428 · Cited by 125 · see citing works

Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB1 receptor knockout mice

Mascia, M. S., Obinu, M. C., Ledent, C. A., Parmentier, M., Böhme, G. A., Impérato, A., & Fratta, W. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00656-1 · Cited by 123 · see citing works

Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine

Vela, G., Ruiz-gayo, M., & Fuentes, J. A. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00032-2 · Cited by 118 · see citing works

Reduction of stress‐induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors

Valverde, O., Ledent, C. A., Beslot, F., Parmentier, M., & Roques, B. P. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00929.x · Cited by 111 · see citing works

Cannabinoid receptor antagonist SR141716A decreases operant ethanol self administration in rats exposed to ethanol-vapor chambers.

de Fonseca, F. R., Roberts, A. J., Bilbao, A., Koob, G. F., & Navarro, M. (1999) · PubMed · Cited by 103 · see citing works

Genetic analysis of drug addiction: the role of cAMP response element binding protein

Blendy, J. A., & Maldonado, R. J. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050197 · Cited by 100 · see citing works

The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preference

de Fonseca, F. R., Rubio, P., Martı́n-Calderón, J. L., Caine, S. B., Koob, G. F., & Navarro, M. A. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)00708-f · Cited by 95 · see citing works

Down-regulation of cannabinoid receptor agonist-stimulated [ ]GTPγS binding in synaptic plasma membrane from chronic ethanol exposed mouse

Basavarajappa, B. S., & Hungund, B. L. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01072-5 · Cited by 90 · see citing works

Involvement of Dynorphin B in the Antinociceptive Effects of the Cannabinoid CP55,940 in the Spinal Cord

Pugh, G., Mason, D. J., Combs, V., & Welch, S. P. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36640-6 · Cited by 81 · see citing works

Modulation of rat brain cannabinoid receptors after chronic morphine treatment

Rubino, T., Tizzoni, L., Viganò, D., Massi, P., & Parolaro, D. (1997) · Neuroreport · doi:10.1097/00001756-199710200-00007 · Cited by 77 · see citing works

Cannabinoid modulation of drug reward and the implications of marijuana legalization

Covey, D. P., Wenzel, J. M., & Cheer, J. F. (2014) · Brain Research · doi:10.1016/j.brainres.2014.11.034 · Cited by 75 · see citing works

Preferential inhibition of inducible nitric oxide synthase by ebselen

Hattori, R., Inoue, R., Sase, K., Eizawa, H., Kosuga, K., Aoyama, T., Masayasu, H., Kawai, C., Sasayama, S., & Yui, Y. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90179-1 · Cited by 62 · see citing works

Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndrome

Rubino, T., Massi, P., Viganò, D., Fuzio, D., & Parolaro, D. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00547-6 · Cited by 61 · see citing works

Molecular Mechanisms of Opiate Receptor Coupling to G Proteins and Effector Systemsa

Reisine, T., Law, S. F., Blake, A. D., & Tallent, M. K. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb15121.x · Cited by 55 · see citing works

Heroin self-administration in dependent Wistar rats: increased sensitivity to naloxone

Carrera, M. R. A., Schulteis, G., & Koob, G. F. (1999) · Psychopharmacology · doi:10.1007/s002130050983 · Cited by 45 · see citing works

Antagonism of delta(2)-opioid receptors by naltrindole-5'-isothiocyanate attenuates heroin self-administration but not antinociception in rats.

Martin, T. J., Kim, S. A., Cannon, D. G., Sizemore, G. M., Bian, D., Porreca, F., & Smith, J. E. (2000) · PubMed · Cited by 28 · see citing works

δ-9-Tetrahydrocannabinol regulates substance P and enkephalin mRNAs levels in the caudate-putamen

Mailleux, P., & Vanderhaeghen, J. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90234-8 · Cited by 22 · see citing works

Anatomically Specific Changes in the Expression of Somatostatin, Growth Hormone‐Releasing Hormone and Growth Hormone Receptor mRNA in Diabetic Rats

Busiguina, Argente, J., García‐Segura, L. M., & Chowen, J. A. (2000) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2000.00416.x · Cited by 19 · see citing works

A diminution of Δ9-tetrahydrocannabinol modulation of dynorphin A-(1–17) in conjunction with tolerance development

Mason, D. J., Lowe, J. A., III, & Welch, S. P. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00542-7 · Cited by 19 · see citing works

Antagonism of δ2-Opioid Receptors by Naltrindole-5′-isothiocyanate Attenuates Heroin Self-Administration but Not Antinociception in Rats

Martin, T. J., Kim, S. A., Cannon, D. G., Sizemore, G. M., Bian, D., Porreca, F., & Smith, J. E. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39161-x · Cited by 17 · see citing works

The Endocannabinoid System as an Emerging Target of Pharmacotherapy

Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077 · see citing works

REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade

Tzschentke, T. M. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00070.x · Cited by 1,336 · see citing works

The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abuse?

Pierce, R. C., & Kumaresan, V. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.04.016 · Cited by 913 · see citing works

Involvement of the endocannabinoid system in drug addiction

Maldonado, R. J., Valverde, O., & Berrendero, F. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.01.008 · Cited by 584 · see citing works

THE ENDOCANNABINOID SYSTEM: PHYSIOLOGY AND PHARMACOLOGY

de Fonseca, F. R., del Arco, I., Bermúdez‐Silva, F. J., Bilbao, A., Cippitelli, A., & Navarro, M. (2004) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh110 · Cited by 409 · see citing works

SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats

Cohen, C., Perrault, G., Voltz, C., Steinberg, R., & Soubrié, P. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200209000-00018 · Cited by 396 · see citing works

Endocannabinoid Hedonic Hotspot for Sensory Pleasure: Anandamide in Nucleus Accumbens Shell Enhances ‘Liking’ of a Sweet Reward

Mahler, S. V., Smith, K. S., & Berridge, K. C. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301376 · Cited by 377 · see citing works

Cannabinoids, opioids and eating behavior: The molecular face of hedonism?

Cota, D., Tschöp, M. H., Horvath, T. L., & Levine, A. S. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.10.004 · Cited by 330 · see citing works

Endogenous cannabinoid system as a modulator of food intake

Cota, D., Marsicano, G., Lutz, B., Vicennati, V., Stalla, G. K., Pasquali, R., & Pagotto, U. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802250 · Cited by 313 · see citing works

Synergistic interactions between cannabinoid and opioid analgesics

Cichewicz, D. L. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.09.038 · Cited by 305 · see citing works

Cannabinoid CB1 Receptor Antagonists as Promising New Medications for Drug Dependence

Foll, B. L., & Goldberg, S. R. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.077974 · Cited by 290 · see citing works

Adolescent Cannabis Exposure Alters Opiate Intake and Opioid Limbic Neuronal Populations in Adult Rats

Ellgren, M., Spano, S., & Hurd, Y. L. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301127 · Cited by 287 · see citing works

Cannabinoids: reward, dependence, and underlying neurochemical mechanisms?a review of recent preclinical data

Tanda, G., & Goldberg, S. R. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1485-z · Cited by 280 · see citing works

Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9-THC: Mechanism underlying greater toxicity?

Fantegrossi, W. E., Moran, J. H., Radominska-p, A., & Prather, P. L. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.09.017 · Cited by 261 · see citing works

ΔFosB Induction in Striatal Medium Spiny Neuron Subtypes in Response to Chronic Pharmacological, Emotional, and Optogenetic Stimuli

Lobo, M. K., Zaman, S., Damez-Werno, D. M., Koo, J. W., Bagot, R. C., DiNieri, J. A., Nugent, A., Finkel, E., Chaudhury, D., Chandra, R., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1875-13.2013 · Cited by 245 · see citing works

Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716)

Cohen, C., Perrault, G., Griebel, G., & Soubrié, P. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300541 · Cited by 251 · see citing works

The endocannabinoid system in brain reward processes

Solinas, M., Goldberg, S. R., & Piomelli, D. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.130 · Cited by 243 · see citing works

The endogenous opioid system: A common substrate in drug addiction

Trigo, J. M., Martín‐García, E., Berrendero, F., Robledo, P., & Maldonado, R. J. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.10.011 · Cited by 240 · see citing works

Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence

Castañé, A., Valjent, E., Ledent, C. A., Parmentier, M., Maldonado, R. J., & Valverde, O. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00118-1 · Cited by 240 · see citing works

The endocannabinoid system: emotion, learning and addiction

Moreira, F. A., & Lutz, B. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00104.x · Cited by 222 · see citing works

Self-administration of ?9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys

Justinová, Z., Tanda, G., Redhi, G. H., & Goldberg, S. R. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1484-0 · Cited by 221 · see citing works

Involvement of the opioid system in the anxiolytic-like effects induced by Δ9-tetrahydrocannabinol

Berrendero, F., & Maldonado, R. J. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1144-9 · Cited by 221 · see citing works

Cannabinoid CB1 receptors control conditioned drug seeking

Vries, T. J. D., & Schoffelmeer, A. N. M. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.06.002 · Cited by 219 · see citing works

Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors

Urigüen, L., Pérez-Rial, S., Ledent, C., Palomo, T., & Manzanares, J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.01.003 · Cited by 218 · see citing works

Braking Dopamine Systems: A New GABA Master Structure for Mesolimbic and Nigrostriatal Functions

Barrot, M., Sesack, S. R., Georges, F. E., Pistis, M., Hong, S., & Jhou, T. C. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.3370-12.2012 · Cited by 215 · see citing works

Marijuana and the Cannabinoids

ElSohly, M. A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-947-9 · Cited by 217 · see citing works

Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal

Scavone, J. L., Sterling, R. C., & Van Bockstaele, E. J. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.034 · Cited by 209 · see citing works

Cannabinoid Addiction: Behavioral Models and Neural Correlates

Maldonado, R. J., & de Fonseca, F. R. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03326.2002 · Cited by 205 · see citing works

Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats

Vries, T. J. D., Homberg, J. R., Binnekade, R., Raasø, H. S., & Schoffelmeer, A. N. M. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1422-1 · Cited by 197 · see citing works

Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons.

Pistis, M., Perra, S., Pillolla, G., Melis, M., Muntoni, A. L., & Gessa, G. L. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.05.006 · Cited by 194 · see citing works

Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings

Morgan, C. J. A., Das, R., Joye, A., Curran, H. V., & Kamboj, S. K. (2013) · Addictive Behaviors · doi:10.1016/j.addbeh.2013.03.011 · Cited by 194 · see citing works

The Cannabinoid CB1 Antagonist N-Piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) Differentially Alters the Reinforcing Effects of Heroin under Continuous Reinforcement, Fixed Ratio, and Progressive Ratio Schedules of Drug Self-Administration in Rats

Solinas, M., Panlilio, L. V., Antoniou, K., Pappas, L., & Goldberg, S. R. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.047928 · Cited by 194 · see citing works

Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia

Mátyás, F., Yanovsky, Y., Mackie, K., Kelsch, W., Misgeld, U., & Freund, T. F. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.09.005 · Cited by 191 · see citing works

CB1 Receptor Knockout Mice Display Reduced Ethanol-Induced Conditioned Place Preference and Increased Striatal Dopamine D2 Receptors

Houchi, H., Babovic, D., Pierrefiche, O., Ledent, C. A., Daoust, M., & Naassïla, M. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300568 · Cited by 181 · see citing works

Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors

Serrano, A., & Parsons, L. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.005 · Cited by 180 · see citing works

Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats

Economidou, D., Mattioli, L., Cifani, C., Perfumi, M. C., Massi, M., Cuomo, V., Trabace, L., & Ciccocioppo, R. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0199-9 · Cited by 169 · see citing works

Molecular and cellular basis of cannabinoid and opioid interactions

Viganò, D., Rubino, T., & Parolaro, D. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.021 · Cited by 167 · see citing works

Genetic Impairment of Frontocortical Endocannabinoid Degradation and High Alcohol Preference

Hansson, A. C., Bermúdez‐Silva, F. J., Malinen, H., Hyytiä, P., Sánchez-Vera, I., Rimondini, R., de Fonseca, F. R., Kunos, G., Sommer, W. H., & Heilig, M. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301034 · Cited by 164 · see citing works

Reversal of Δ9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine

Williams, C. M., & Kirkham, T. C. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00694-3 · Cited by 158 · see citing works

Emerging Evidence for Cannabis' Role in Opioid Use Disorder

Wiese, B. M., & Wilson‐Poe, A. R. (2018) · Cannabis and Cannabinoid Research · doi:10.1089/can.2018.0022 · Cited by 156 · see citing works

Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling

Wenzel, J. M., & Cheer, J. F. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.126 · Cited by 154 · see citing works

Δ9-Tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats

Braida, D., Iosuè, S., Pegorini, S., & Sala, M. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.10.043 · Cited by 152 · see citing works

Prenatal Cannabis Exposure Increases Heroin Seeking with Allostatic Changes in Limbic Enkephalin Systems in Adulthood

Spano, M. S., Ellgren, M., Wang, X., & Hurd, Y. L. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.073 · Cited by 150 · see citing works

Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout mice

Naassïla, M., Pierrefiche, O., Ledent, C. A., & Daoust, M. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.09.002 · Cited by 150 · see citing works

Absence of Δ-9-Tetrahydrocannabinol Dysphoric Effects in Dynorphin-Deficient Mice

Zimmer, A., Valjent, E., König, M., Zimmer, A. M., Robledo, P., Hahn, H., Valverde, O., & Maldonado, R. J. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09499.2001 · Cited by 140 · see citing works

Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol‐seeking behavior in rats

Cippitelli, A., Bilbao, A., Hansson, A. C., del Arco, I., Sommer, W. H., Heilig, M. A., Massi, M., Bermúdez‐Silva, F. J., Navarro, M., Ciccocioppo, R., et al. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04056.x · Cited by 141 · see citing works

Rewarding and psychomotor stimulant effects of endomorphin-1: anteroposterior differences within the ventral tegmental area and lack of effect in nucleus accumbens

Zangen, A., Ikemoto, S., Zadina, J. E., & Wise, R. A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07225.2002 · Cited by 138 · see citing works

Self-administration of cannabinoids by experimental animals and human marijuana smokers

Justinová, Z., Goldberg, S. R., Heishman, S. J., & Tanda, G. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.026 · Cited by 137 · see citing works

Molecular biology of cannabinoid receptors

Lutz, B. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0342 · Cited by 135 · see citing works

The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction

López‐Moreno, J. A., González‐Cuevas, G., Moreno, G., & Navarro, M. A. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00105.x · Cited by 132 · see citing works

Cannabinoid mechanism in reinstatement of heroin‐seeking after a long period of abstinence in rats

Fattore, L., Spano, M. S., Cossu, G., Deiana, S., & Fratta, W. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02607.x · Cited by 128 · see citing works

Targeting dopamine D2 and cannabinoid‐1 (CB1) receptors in rat nucleus accumbens

Pickel, V. M., Chan, J., Kearn, C. S., & Mackie, K. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.20881 · Cited by 128 · see citing works

Actions of delta-9-tetrahydrocannabinol in cannabis: Relation to use, abuse, dependence

Cooper, Z. D., & Haney, M. (2009) · International Review of Psychiatry · doi:10.1080/09540260902782752 · Cited by 127 · see citing works

Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Potential

Tai, S., & Fantegrossi, W. E. (2014) · Current Addiction Reports · doi:10.1007/s40429-014-0014-y · Cited by 127 · see citing works

Endocannabinoid System Modulates Relapse to Methamphetamine Seeking: Possible Mediation by the Arachidonic Acid Cascade

Anggadiredja, K., Nakamichi, M., Hiranita, T., Tanaka, H., Shoyama, Y., Watanabe, S., & Yamamoto, T. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300454 · Cited by 125 · see citing works

Interactions between CB1 cannabinoid and μ opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core

Schoffelmeer, A. N. M., Hogenboom, F., WARDEH, G., & Vries, T. J. D. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.05.019 · Cited by 124 · see citing works

Advances in the field of cannabinoid–opioid cross‐talk

Robledo, P., Berrendero, F., Ozaita, A., & Maldonado, R. J. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00107.x · Cited by 120 · see citing works

Mechanisms Underlying Sex Differences in Cannabis Use

Calakos, K. C., Bhatt, S., Foster, D. W., & Cosgrove, K. (2017) · Current Addiction Reports · doi:10.1007/s40429-017-0174-7 · Cited by 121 · see citing works

Decreased Cocaine Motor Sensitization and Self-Administration in Mice Overexpressing Cannabinoid CB2 Receptors

Aracil-Fernández, A., Trigo, J. M., García‐Gutiérrez, M. S., Ortega-Álvaro, A., Ternianov, A., Navarro, D., Robledo, P., Berbel, P. J., Maldonado, R. J., & Manzanares, J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.22 · Cited by 119 · see citing works

Cannabinoid CB1receptor‐interacting proteins: novel targets for central nervous system drug discovery?

Smith, T. H., Sim‐Selley, L. J., & Selley, D. E. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00777.x · Cited by 117 · see citing works

Cannabinoid Modulation of Opiate Reinforcement through the Ventral Striatopallidal Pathway

Caillé, S., & Parsons, L. H. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300848 · Cited by 118 · see citing works

Ghrelin and food reward: The story of potential underlying substrates

Skibicka, K. P., & Dickson, S. L. (2011) · Peptides · doi:10.1016/j.peptides.2011.05.016 · Cited by 116 · see citing works

Role of the endocannabinoid system in drug addiction

Manzanares, J., Cabañero, D., Puente, N., García‐Gutiérrez, M. S., Grandes, P., & Maldonado, R. J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.09.013 · Cited by 116 · see citing works

Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats

Forget, B., Hamon, M., & Thiébot, M.-H. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0015-6 · Cited by 115 · see citing works

Endocannabinoid system and alcohol addiction: Pharmacological studies

Colombo, G., SERRA, S., VACCA, G., Carai, M. A. M., & GESSA, G. L. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.022 · Cited by 114 · see citing works

Opioid Antagonism of Cannabinoid Effects: Differences between Marijuana Smokers and Nonmarijuana Smokers

Haney, M. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301243 · Cited by 113 · see citing works

Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole – LH 21

Pavón, F. J., Bilbao, A., Hernández‐Folgado, L., Cippitelli, A., Jagerovic, N., Abellán, G., Rodrı́guez-Franco, M. I., Serrano, A., Macías, M., de Heras, R. G., et al. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.03.029 · Cited by 113 · see citing works

Endocannabinoid system and opioid addiction: Behavioural aspects

Fattore, L., Deiana, S., Spano, S., Cossu, G., Fadda, P., Scherma, M., & Fratta, W. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.031 · Cited by 112 · see citing works

Signaling via CNS cannabinoid receptors

Mackie, K. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.01.022 · Cited by 112 · see citing works

The opioid antagonist naltrexone reduces the reinforcing effects of ? 9 -tetrahydrocannabinol (THC) in squirrel monkeys

Tanda, G., Munzar, P., Goldberg, S. R., & Justinova, Z. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1693-6 · Cited by 111 · see citing works

The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940)

Ward, S. J., & Dykstra, L. A. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00010 · Cited by 111 · see citing works

An endocannabinoid mechanism in relapse to drug seeking: A review of animal studies and clinical perspectives

Fattore, L., Spano, M. S., Deiana, S., Melis, V., Cossu, G., Fadda, P., & Fratta, W. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.05.003 · Cited by 109 · see citing works

A Role for the Endocannabinoid System in the Increased Motivation for Cocaine in Extended-Access Conditions

Orío, L., Edwards, S., George, O., Parsons, L. H., & Koob, G. F. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0563-09.2009 · Cited by 109 · see citing works

Pharmacotherapy for Cannabis Dependence

Vandrey, R. G., & Haney, M. (2009) · CNS Drugs · doi:10.2165/00023210-200923070-00001 · Cited by 109 · see citing works

Inhibition of FAAH and activation of PPAR: New approaches to the treatment of cognitive dysfunction and drug addiction

Panlilio, L. V., Justinová, Z., & Goldberg, S. R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.003 · Cited by 106 · see citing works

AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: Implications for opioid/cannabinoid interaction studies

Seely, K. A., Brents, L. K., Franks, L. N., Rajasekaran, M., Zimmerman, S. M., Fantegrossi, W. E., & Prather, P. L. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.046 · Cited by 103 · see citing works

Synthetic Pot: Not Your Grandfather’s Marijuana

Ford, B. M., Tai, S., Fantegrossi, W. E., & Prather, P. L. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.12.003 · Cited by 102 · see citing works

Molecular Mechanisms of Placebo Responses In Humans

Peciña, M., & Zubieta, J. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.164 · Cited by 96 · see citing works

Endocannabinoid system involvement in brain reward processes related to drug abuse

Solinas, M., Yaşar, S., & Goldberg, S. R. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.005 · Cited by 96 · see citing works

FAAH selectively influences placebo effects

Peciña, M., Martínez-Jauand, M., Hodgkinson, C. A., Stohler, C. S., Goldman, D. A., & Zubieta, J. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.124 · Cited by 96 · see citing works

Cannabinoid Agonists but not Inhibitors of Endogenous Cannabinoid Transport or Metabolism Enhance the Reinforcing Efficacy of Heroin in Rats

Solinas, M., Panlilio, L. V., Tanda, G., Makriyannis, A., Matthews, S. A., & Goldberg, S. R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300754 · Cited by 96 · see citing works

Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine

Viganò, D., Valenti, M., Cascio, M. G., Marzo, V. D., Parolaro, D., & Rubino, T. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03645.x · Cited by 97 · see citing works

Signal Transduction via Cannabinoid Receptors

Dalton, G. D., Bass, C. E., Horn, C. V., & Howlett, A. C. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824615 · Cited by 94 · see citing works

CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid‐seeking behaviour in the rat

Spano, M. S., Fattore, L., Cossu, G., Deiana, S., Fadda, P., & Fratta, W. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705932 · Cited by 95 · see citing works

Chronic Morphine Modulates the Contents of the Endocannabinoid, 2-Arachidonoyl Glycerol, in Rat Brain

Viganò, D., Cascio, M. G., Rubino, T., Fezza, F., Vaccani, A., Marzo, V. D., & Parolaro, D. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300117 · Cited by 95 · see citing works

Why Should We Keep the Cerebellum in Mind When Thinking About Addiction?

Miquel, M., Toledo‐Cárdenas, M. R., García, L. I., Coria‐Ávila, G. A., & Manzo, J. (2009) · Current Drug Abuse Reviews · doi:10.2174/1874473710902010026 · Cited by 93 · see citing works

Endocannabinoid-mediated synaptic plasticity and addiction-related behavior

Sidhpura, N., & Parsons, L. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.05.034 · Cited by 92 · see citing works

In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid Δ9-THC in mice: Inhalation versus intraperitoneal injection

Marshell, R., Kearney-Ramos, T. E., Brents, L. K., Hyatt, W. S., Tai, S., Prather, P. L., & Fantegrossi, W. E. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.05.010 · Cited by 90 · see citing works

Rimonabant: The first therapeutically relevant cannabinoid antagonist

Carai, M. A. M., Colombo, G., & Gessa, G. L. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.04.017 · Cited by 90 · see citing works

Bidirectional regulation of mu‐opioid and CB1‐cannabinoid receptor in rats self‐administering heroin or WIN 55,212‐2

Fattore, L., Viganò, D., Fadda, P., Rubino, T., Fratta, W., & Parolaro, D. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05470.x · Cited by 89 · see citing works

Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study

Pistis, M., Muntoni, A. L., Pillolla, G., & Gessa, G. L. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02019.x · Cited by 88 · see citing works

Reduced neural response to reward following 7 days treatment with the cannabinoid CB1 antagonist rimonabant in healthy volunteers

Horder, J., Harmer, C. J., Cowen, P. J., & McCabe, C. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000453 · Cited by 88 · see citing works

Cannabis: A Treasure Trove or Pandora's Box?

Solymosi, K., & Köfalvi, A. (2016) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557516666161004162133 · Cited by 88 · see citing works

Cannabinoid CB1 antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats

Fattore, L., Spano, S., Cossu, G., Deiana, S., Fadda, P., & Fratta, W. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.01.022 · Cited by 87 · see citing works

The Role of the Ghrelin System in Drug Addiction

Zallar, L. J., Farokhnia, M., Tunstall, B. J., Vendruscolo, L. F., & Leggio, L. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.08.002 · Cited by 87 · see citing works

Cannabinoid Regulation of Brain Reward Processing with an Emphasis on the Role of CB1 Receptors: A Step Back into the Future

Panagis, G., Mackey, B., & Vlachou, S. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00092 · Cited by 86 · see citing works

Constitutive Activity of the Cannabinoid CB1 Receptor Regulates the Function of Co-expressed Mu Opioid Receptors

Canals, M., & Milligan, G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710300200 · Cited by 86 · see citing works

Blockade of THC-Seeking Behavior and Relapse in Monkeys by the Cannabinoid CB1-Receptor Antagonist Rimonabant

Justinová, Z., Munzar, P., Panlilio, L. V., Yaşar, S., Redhi, G. H., Tanda, G., & Goldberg, S. R. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.21 · Cited by 86 · see citing works

Impact of Cannabis Use during Stabilization on Methadone Maintenance Treatment

Scavone, J. L., Sterling, R. C., Weinstein, S. P., & Bockstaele, E. J. V. (2013) · American Journal on Addictions · doi:10.1111/j.1521-0391.2013.12044.x · Cited by 85 · see citing works

Uso terapêutico dos canabinoides em psiquiatria

Crippa, J. A. S., Zuardi, A. W., & Hallak, J. E. C. (2010) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462010000500009 · Cited by 85 · see citing works

CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats

Navarro, M., Chowen, J., Carrera, M. R. A., del Arco, I., Villanúa, M. A., Martin, Y., Roberts, A. J., Koob, G. F., & de Fonseca, F. R. (1998) · NeuroReport · doi:10.1097/00001756-199810260-00012 · Cited by 152 · see citing works

Cannabinoid receptor antagonist reduces heroin self-administration only in dependent rats

Navarro, M., Carrera, M. R. A., del Arco, I., Trigo, J. M., Koob, G. F., & de Fonseca, F. R. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.08.022 · Cited by 34 · see citing works

Reduction of opioid dependence by the CB1 antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction

Nieto, M. M., Pommier, B., Tzavara, E. T., Caneparo, A., Nascimento, S. D., Fur, G. L., Roques, B. P., & Noble, F. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703990 · Cited by 111 · see citing works

Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.

Lichtman, A. H., Sheikh, S. M., Loh, H. H., & Martin, B. R. (2001) · PubMed · Cited by 156 · see citing works

Cannabinoid Modulation of Opiate Reinforcement through the Ventral Striatopallidal Pathway

Caillé, S., & Parsons, L. H. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300848 · Cited by 118 · see citing works